Navigation Links
Federal NuvaRing Blood-Clotting Lawsuits Report: Resource4thePeople Updates Consumers with News That First Bellwether Trial Rescheduled to July
Date:3/2/2013

San Diego CA (PRWEB) March 02, 2013

In its latest update to consumers about the progress of more than 1,000 lawsuits involving claims that the NuvaRing contraceptive puts women at higher risk of blood clotting, Resource4thePeople is reporting today that the first bellwether trial in the litigation* has been rescheduled to July. http://www.resource4thepeople.com/defectivedrugs/nuvaring.html

"In continuing to update consumers about these important cases, which may have ramifications for the millions of women who chose the NuvaRing as their method of contraception, we have to report that the first bellwether, or test trial, in the litigation will not be as early as first anticipated," said Resource4thePeople.

"This trial has been rescheduled several times but Judge Rodney Sippel has now put on the record that in his view July is the best month in order to accommodate the needs of both plaintiffs and defendants.

"We will continue to monitor the progress of this litigation and provide the latest news for the increasing number of women who have been contacting us for information about this important litigation."

Resource4thePeople announced that it will continue to provide lawyers offering free consultations to women who may have suffered severe health problems as a result of their use of the NuvaRing intrauterine device.

"The question we have frequently been receiving is whether it is too late to file a lawsuit as this litigation before Judge Sippel proceeds," said Resource4thePeople. "The answer, in most cases, is no."

For instance, said Resource4thePeople, one of the most recent such NuvaRing lawsuits** was filed last week by a Philadelphia woman who claims she suffered a venous sinus thrombosis and an intracranial hemorrhage last year.

In her lawsuit, the woman is claiming that those problems were caused by blood clotting caused by her use of a NuvaRing IUD over seven years.

In her court filing, the woman said she has been forced to undergo a daily Coumadin regimen for her health problems, and suffers from depression and social anxiety.

Named as defendants are Organon Pharmaceuticals USA Inc., Organon International Inc. and Schering-Plough Corp., who, according to the court file, allegedly falsely marketed and sold the NuvaRing as a safe, efficient alternative to birth control pills.

As with the NuvaRing lawsuits in the multidistrict litigation, the Philadelphia woman claims that the defendants were negligent in not fully informing the public and health care professionals about increased risk of blood-clotting from the use of the contraceptive, according to the court filing.

The allegations cited in the multidistrict litigation claim that the NuvaRing, described by company officials as the first hormonal IUD, puts women at risk of suffering blood clots that can lead to life-threatening health problems because of the hormone mixture that prevents pregnancies.

The NuvaRing was approved by the Food and Drug Administration in 2001 after being created by Organon as a flexible IUD, or ring, hence the name. The IUD releases a low dose of etonogestrel and estrogen over three weeks, providing women the flexibility of a monthly contraceptive.

This flexibility was one of the marketing factors that made the NuvaRing what was described as an easy and healthy contraceptive choice to women who were not satisfied with the side effects caused by birth control pills and the necessity of taking them each day.

However, by 2011 the FDA released the findings of government research that put women who used the NuvaRing or other IUDs with a similar mixture of hormones at a 56 percent higher risk of suffering blood clotting that led to deep vein thrombosis and pulmonary embolisms than women on birth control pills.***

Resource4thePeople is committed to informing women about the risks they may face in their choices of contraception and providing them data that ensures the protection of their health and that of any infants they may give birth to who may be exposed to side effects from contraceptive devices.

In announcing that free legal consultations are still being offered to women who may have suffered serious side effects from the use of the NuvaRing, Resource4thePeople notes that NuvaRing has now posted warnings about the increased risks of suffering blood clots on the company’s web site under the heading of “IMPORTANT SAFETY INFORMATION.****

"Our legal consultations can spell out the options available to women who may have suffered health problems from blood clotting, such as deep vein thrombosis, pulmonary embolisms, strokes and heart attacks," said Resource4thePeople.

Legal assistance also is available to those who may have lost a loved one and may be seeking information about the facts involved in a wrongful death.

“This announcement is being made in case there is any confusion among women who might have suffered serious health problems similar to those alleged in what is now a large, consolidated federal court proceeding,” said Resource4thePeople.

Multidistrict litigations are designated by a special panel of federal judges in cases in which large numbers of plaintiffs file similar allegations against common defendants in the interest of judicial efficiency and to avoid duplicative and conflicting legal proceedings.

In such litigations the judge oversees pre-trial evidence-gathering and legal requirements, schedules bellwether cases to allow both plaintiffs and defendants to weigh the strengths and weaknesses of their cases and presides over mediations and settlement discussions.

The judge is also asked to rule on whether such cases should be certified as class-action cases, in which a large pool of plaintiffs are given the choice of whether to remain in the litigation or proceed with their individual case outside of the outcome of the class action.

Sources:

  • In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, U.S. District Court, Eastern District of Missouri
** Case No. 2:13cv0099, U.S. District Court for the Eastern District of Pennsylvania
***http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
**** http://www.nuvaring.com/Consumer/index.asp

Read the full story at http://www.prweb.com/releases/2013/3/prweb10484983.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Wright Hip Implant Lawyers at Bernstein Liebhard LLP Note Scheduling of Next Status Conference in Federal Wright Conserve Hip Replacement Litigation
2. Massachusetts' Deval Patrick Wins "Green Governor of the Year Award" -- First State to Win Federal Approval for Offshore Wind Farms says BE
3. Securityhunter Hires DigitalFury Technologies to Furnish Program Management Support for Federal Electronic Security System Programs
4. The ethics of access: Comparing 2 federal health care reform efforts
5. Federal Way Retirement Community to Host Event on Senior Living Options and Special Programs
6. Michigan Criminal Attorney, Loren Dickstein, Successfully Assists Client with Avoiding Serving Time in Federal Prison
7. North Shore-LIJ awarded $300,000 federal grant for prostate cancer research training
8. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
9. DePuy ASR Hip Recall: Status Conference Held in Federal DePuy ASR Hip Litigation in Ohio
10. DePuy Pinnacle Lawsuits: Explant Preservation Order Issued in Federal DePuy Pinnacle Hip Litigation
11. Actos Bladder Cancer Lawsuits: Next Status Conference in Federal Actos Litigation Scheduled for January 24, 2013, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
Breaking Medicine Technology: